The Effect of Local Nasal Immunotherapy in Allergic Rhinitis: Using Strips of the Allergen Dermatophagoides pteronyssinus

References

• Meltzer E O. The prevalence and medical and economic impact of allergic rhinitis in the United States. J Allergy Clin Immuno 1997; 99: S805–S828
   PubMed Web of Science ®Google Scholar
• Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46: 895–901
   PubMed Web of Science ®Google Scholar
• Tsai J J, Ho C Y, Wang S R. Relationship between nasal resistance and airway hyperreactivity following nasal provocation with Dermatophagoides pteronyssinus in allergic rhinitis. Int Arch Allergy Immunol 1995; 106: 286–290
   PubMed Web of Science ®Google Scholar
• Corren J, Harris A G, Aaronson D, Beaucher W, Berkowitz R, Bronsky E, Chen R, Chervinsky P, Cohen R, Fourre J, Grossman J, Meltzer E, Pedinoff A, Stricker W, Wanderer A. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997; 100: 781–788
   PubMed Web of Science ®Google Scholar
• Howarth P H, Persson C G, Meltzer E O, Jacobson M R, Durham S R, Silkoff P E. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 2005; 115: S414–S441
   PubMedGoogle Scholar
• Tsai J J, Kao M H, Huang S L. Comparison of major aeroallergens in Taipei and Kin-Men. J Formos Med Assoc 1997; 96: 985–989
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling H J, Alvarez-Cuesta E, Canonica G W, Chapman M D, Creticos P J, Dayer J M, Durham S R, Demoly P, Goldstein R J, Ishikawa T, Ito K, Kraft D, Lambert P H, Lowenstein H, Muller U, Norman P S, Reisman R E, Valenta R, Valovirta E, Yssel H. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998; 81: 401–405
   PubMed Web of Science ®Google Scholar
• Aalberse R C, van der Gaag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983; 130: 722–726
   PubMed Web of Science ®Google Scholar
• Wilson D R, Irani A M, Walker S M, Jacobson M R, Mackay I S, Schwartz L B, Durham S R. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001; 31: 1705–1713
   PubMed Web of Science ®Google Scholar
• Lockey R F, Nicoara-Kasti G L, Theodoropoulos D S, Bukantz S C. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001; 87: 47–55
   PubMed Web of Science ®Google Scholar
• Tinkelman D G, Cole W Q, 3rd, Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995; 95: 8–14
   PubMed Web of Science ®Google Scholar
• Reid M J, Lockey R F, Turkeltaub P C, Platts-Mills T A. Survey of fatalities from skin testing and immunotherapy 1985–1989. J Allergy Clin Immunol 1993; 92: 6–15
   PubMed Web of Science ®Google Scholar
• Bousquet J LR, Malling H J, Alvarez-Cuesta E, Canonica G W, Chapman M D, Creticos P J, Dayer J M, Durham S R, Demoly P, Goldstein R J, Ishikawa T, Ito K, Kraft D, Lambert P H, Løwenstein H, Müller U, Norman P S, Reisman R E, Valenta R, Valovirta E, Yssel H. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. Ann Allergy Asthma Immunol 1998; 47: 698–704
   Google Scholar
• Malling H J, Abreu-Nogueira J, Alvarez-Cuesta E, Bjorksten B, Bousquet J, Caillot D. Local immunotherapy. Allergy 1998; 53: 933–944
   PubMed Web of Science ®Google Scholar
• Pajno G B, Vita D, Caminiti L, Arrigo T, Lombardo F, Incorvaia C. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 2005; 116: 1380–1381
   PubMed Web of Science ®Google Scholar
• Motta G, Passali D, De Vincentiis I, Ottaviani A, Maurizi M, Sartoris A. A multicenter trial of specific local nasal immunotherapy. Laryngoscope 2000; 110: 132–139
   PubMed Web of Science ®Google Scholar
• Andri L, Senna G, Betteli C, Givanni S, Andri G, Falagiani P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol 1993; 91: 987–996
   PubMed Web of Science ®Google Scholar
• Tsai J J, Shen H D, Chua K Y. Purification of group 2 Dermatophagoides pteronyssinus allergen and prevalence of its specific IgE in asthmatics. Int Arch Allergy Immunol 2000; 121: 205–210
   PubMed Web of Science ®Google Scholar
• Tsai J J, Su Y C, Chan S C, Ho C K, Feng T C. Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy. J Formos Med Assoc 2001; 100: 241–243
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Kaneuchi T, Miura T, Kimura M. Kinetic analysis of the fluorescence reaction of histamine with orthophthalaldehyde. Anal Biochem 1987; 164: 132–137
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Mansueto P, Melluso M, Candore G, Colombo A, Pellitteri M E. Allergic rhinitis to grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season. J Allergy Clin Immunol 1997; 100: 832–837
   PubMed Web of Science ®Google Scholar
• Georgitis J W, Reisman R E, Clayton W F, Mueller U R, Wypych J I, Arbesman C E. Local intranasal immunotherapy for grass-allergic rhinitis. J Allergy Clin Immunol 1983; 71: 71–76
   PubMed Web of Science ®Google Scholar
• Georgitis J W, Clayton W F, Wypych J I, Barde S H, Reisman R E. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts. J Allergy Clin Immunol 1984; 74: 694–700
   PubMed Web of Science ®Google Scholar
• Liu Y H, Kao M C, Lai Y L, Tsai J J. Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: Using Dp2 peptide and fungal immunomodulatory peptide. J Allergy Clin Immunol 2003; 112: 301–310
   PubMed Web of Science ®Google Scholar
• Liu Y H, Tsai J J. Production of salivary immunoglobulin A and suppression of Dermatophagoides pteronyssinus-induced airway inflammation by local nasal immunotherapy. Int Arch Allergy Immunol 2005; 138: 161–168
   PubMed Web of Science ®Google Scholar
• Andri L, Senna G, Andri G, Dama A, Givanni S, Betteli C, Dimitri G, Falagiani P, Mezzelani P. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995; 25: 1092–1099
   PubMed Web of Science ®Google Scholar
• Bardare M, Zani G, Novembre E, Vierucci A. Local nasal immunotherapy with a powder extract for grass pollen induced rhinitis in pediatric ages: a controlled study. J Investig Allergol Clin Immunol 1996; 6: 359–363
   PubMed Web of Science ®Google Scholar
• Bertoni M, Cosmi F, Bianchi I, Di Berardino L. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis. Ann Allergy Asthma Immunol 1999; 82: 47–51
   PubMed Web of Science ®Google Scholar
• Canonica G W, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437–448, quiz 449
   PubMed Web of Science ®Google Scholar